The P2X7 Receptor in Inflammatory Diseases: Angel or Demon?
Open accessAbstract
Under physiological conditions, adenosine triphosphate (ATP) is present at low levels in the extracellular milieu, being massively released by stressed or dying cells. Once outside the cells, ATP and related nucleotides/nucleoside generated by ectonucleotidases mediate a high evolutionary conserved signaling system: the purinergic signaling, which is involved in a variety of pathological conditions, including inflammatory diseases. Extracellular ATP has been considered an endogenous adjuvant that can initiate inflammation by acting as a danger signal through the activation of purinergic type 2 receptors-P2 receptors (P2Y G-protein coupled receptors and P2X ligand-gated ion channels). Among the P2 receptors, the P2X7 receptor is the most extensively studied from an immunological perspective, being involved in both innate and adaptive immune responses. P2X7 receptor activation induces large-scale ATP release via its intrinsic ability to form a membrane pore or in association with pannexin hemichannels, boosting purinergic signaling. ATP acting via P2X7 receptor is the second signal to the inflammasome activation, inducing both maturation and release of pro-inflammatory cytokines, such as IL-1β and IL-18, and the production of reactive nitrogen and oxygen species. Furthermore, the P2X7 receptor is involved in caspases activation, as well as in apoptosis induction. During adaptive immune response, P2X7 receptor modulates the balance between the generation of T helper type 17 (Th17) and T regulatory (Treg) lymphocytes. Therefore, this receptor is involved in several inflammatory pathological conditions. In infectious diseases and cancer, P2X7 receptor can have different and contrasting effects, being an angel or a demon depending on its level of activation, cell studied, type of pathogen, and severity of infection. In neuroinflammatory and neurodegenerative diseases, P2X7 upregulation and function appears to contribute to disease progression. In this review, we deeply discuss P2X7 receptor dual function and its pharmacological modulation in the context of different pathologies, and we also highlight the P2X7 receptor as a potential target to treat inflammatory related diseases.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
P2X7 receptor modulates acute and chronic infection, inflammatory diseases, sepsis, neuropathic pain, and T-cell activation.
“It was already reported its capacity to modulate acute and chronic infection [81, 82], inflammatory diseases [82], sepsis [83, 84], neuropathic pain [85], and T-cell activation [86].”
From Hyperactivation of P2X7 receptors as a culprit of COVID-19 neuropathology (2021) · cites this paper as [82]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
1 retracted
Tan, C., HAN, L., Zou, L., Chunhua, L., Liu, A., Sheng, X., & Xi, D. (2015) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2015.2705 · Cited by 35 · see citing works
RetractedHallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590 · see citing works
Siegel, R. L., Miller, K. D., & Jemal, A. (2017) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21387 · Cited by 14,712 · see citing works
The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864 · see citing works
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359 · see citing works
Leishmaniasis Worldwide and Global Estimates of Its Incidence
Alvar, J., Vélez, I. D., Bern, C., Herrero, M., Desjeux, P., Cano, J., Jannin, J., Boer, M. D., & the WHO Leishmaniasis Control Team (2012) · PLoS ONE · doi:10.1371/journal.pone.0035671 · Cited by 5,141 · see citing works
Tumor-Associated Macrophages: From Mechanisms to Therapy
Noy, R., & Pollard, J. W. (2014) · Immunity · doi:10.1016/j.immuni.2014.06.010 · Cited by 4,089 · see citing works
Receptors for Purines and Pyrimidines
Burnstock, G., & Verkhratsky, A. (2012) · Springer eBooks · doi:10.1007/978-3-642-28863-0_5 · Cited by 3,973 · see citing works
Molecular Physiology of P2X Receptors
North, R. A. (2002) · Physiological Reviews · doi:10.1152/physrev.00015.2002 · Cited by 2,919 · see citing works
Deaglio, S., Dwyer, K. M., Gao, W., Friedman, D. J., Usheva, A., Erat, A., Chen, J., Enjyoji, K., Linden, J. M., Oukka, M., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20062512 · Cited by 2,478 · see citing works
Paradoxical roles of the immune system during cancer development
de Visser, K. E., Eichten, A., & Coussens, L. M. (2006) · Nature reviews. Cancer · doi:10.1038/nrc1782 · Cited by 2,261 · see citing works
Receptors for Purines and Pyrimidines
Ralevic, V., & Burnstock, G. (1998) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01373-5 · Cited by 2,005 · see citing works
Ghiringhelli, F., Apetoh, L., Tesniere, A., Aymeric, L., Ma, Y., Ortiz, C., Vermaelen, K., Panaretakis, T., Mignot, G., Ullrich, E., et al. (2009) · Nature Medicine · doi:10.1038/nm.2028 · Cited by 1,898 · see citing works
Burnstock, G. (1972) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06930-3 · Cited by 1,852 · see citing works
Alzheimer's Disease and the Amyloid-β Peptide
Murphy, M. P., & LeVine, H. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-1221 · Cited by 1,750 · see citing works
Surprenant, A., Rassendren, F., Kawashima, E., North, R. A., & Buell, G. (1996) · Science · doi:10.1126/science.272.5262.735 · Cited by 1,739 · see citing works
Immunological aspects of cancer chemotherapy
Zitvogel, L., Apetoh, L., Ghiringhelli, F., & Kroemer, G. (2008) · Nature Reviews Immunology · doi:10.1038/nri2216 · Cited by 1,712 · see citing works
Drury, A. N., & Szent‐Györgyi, A. (1929) · The Journal of Physiology · doi:10.1113/jphysiol.1929.sp002608 · Cited by 1,493 · see citing works
-Synuclein in Parkinson's Disease
Stefanis, L. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a009399 · Cited by 1,446 · see citing works
Pannexin‐1 mediates large pore formation and interleukin‐1β release by the ATP‐gated P2X7 receptor
Pelegrı́n, P., & Surprenant, A. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601378 · Cited by 1,428 · see citing works
Abbracchio, M. P., Burnstock, G., Boeynaems, J., Barnard, E. A., Boyer, J. L., Kennedy, C., Knight, G. E., Fumagalli, M., Gachet, C., Jacobson, K. A., et al. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.3.3 · Cited by 1,286 · see citing works
The P2X7 Receptor in Infection and Inflammation
Di Virgilio, F., Dal Ben, D., Sarti, A. C., Giuliani, A. L., & Falzoni, S. (2017) · Immunity · doi:10.1016/j.immuni.2017.06.020 · Cited by 1,267 · see citing works
Inflammatory cortical demyelination in early multiple sclerosis.
Lucchinetti, C. F., Popescu, B. F. G., Bunyan, R. F., Moll, N. M., Roemer, S. F., Lassmann, H., Brück, W., Parisi, J. E., Scheithauer, B. W., Giannini, C., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1100648 · Cited by 1,103 · see citing works
Hotez, P. J., Alvarado, M., Basáñez, M.-G., Bolliger, I. W., Bourne, R., Boussinesq, M., Brooker, S. J., Brown, A. S., Buckle, G. C., Budke, C. M., et al. (2014) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0002865 · Cited by 1,085 · see citing works
A2A adenosine receptor protects tumors from antitumor T cells
Ohta, A., Gorelik, E., Prasad, S. J., Ronchese, F., Lukashev, D. E., Wong, M. K. K., Huang, X., Caldwell, S. A., Liu, K., Smith, P. T., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605251103 · Cited by 1,066 · see citing works
The P2X7 Receptor: A Key Player in IL-1 Processing and Release
Ferrari, D., Pizzirani, C., Adinolfi, E., Lemoli, R. M., Curti, A., Idzko, M., Panther, E., & Di Virgilio, F. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.7.3877 · Cited by 1,025 · see citing works
The ectonucleotidases <scp>CD</scp> 39 and <scp>CD</scp> 73: Novel checkpoint inhibitor targets
Allard, B., Longhi, M. S., Robson, S. C., & Stagg, J. (2017) · Immunological Reviews · doi:10.1111/imr.12528 · Cited by 927 · see citing works
Altered Cytokine Production in Mice Lacking P2X7Receptors
Solle, M., Labasi, J. M., Perregaux, D. G., Stam, E. J., Petrushova, N., Koller, B. H., Griffiths, R., & Gabel, C. A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m006781200 · Cited by 924 · see citing works
Nucleotide signalling during inflammation
Idzko, M., Ferrari, D., & Eltzschig, H. K. (2014) · Nature · doi:10.1038/nature13085 · Cited by 909 · see citing works
Purinergic regulation of the immune system
Cekic, C., & Linden, J. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2016.4 · Cited by 787 · see citing works
Cruz, C. M., Rinna, A., Forman, H. J., Ventura, A. L. M., Persechini, P. M., & Ojcius, D. M. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m608083200 · Cited by 786 · see citing works
Nucleotide receptors: an emerging family of regulatory molecules in blood cells
Virgilio, F. D., Chiozzi, P., Ferrari, D., Falzoni, S., Sanz, J. M., Morelli, A., Torboli, M., Bolognesi, G., & Baricordi, O. R. (2001) · Blood · doi:10.1182/blood.v97.3.587 · Cited by 702 · see citing works
Burnstock, G., Campbell, G. R., Satchell, D. G., et al. (1970) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1970.tb10646.x · Cited by 698 · see citing works
Increased Level of Extracellular ATP at Tumor Sites: In Vivo Imaging with Plasma Membrane Luciferase
Pellegatti, P., Raffaghello, L., Bianchi, G., Piccardi, F., Pistoia, V., & Di Virgilio, F. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002599 · Cited by 668 · see citing works
Ferrari, D., Chiozzi, P., Falzoni, S., Susino, M. D., Melchiorri, L., Baricordi, O. R., & Virgilio, F. D. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.3.1451 · Cited by 616 · see citing works
Yang, D., He, Y., Muñoz-Planillo, R., Liu, Q., & Núñez, G. (2015) · Immunity · doi:10.1016/j.immuni.2015.10.009 · Cited by 602 · see citing works
Hise, A. G., Tomalka, J. A., Ganesan, S., Patel, K., Hall, B. A., Brown, G. D., & Fitzgerald, K. A. (2009) · Cell Host & Microbe · doi:10.1016/j.chom.2009.05.002 · Cited by 568 · see citing works
Qu, Y., Franchi, L., Nunez, G., & Dubyak, G. R. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.3.1913 · Cited by 563 · see citing works
Extracellular purines, purinergic receptors and tumor growth
Virgilio, F. D., & Adinolfi, E. (2016) · Oncogene · doi:10.1038/onc.2016.206 · Cited by 555 · see citing works
Molecular mechanism of ATP binding and ion channel activation in P2X receptors
Hattori, M., & Gouaux, E. (2012) · Nature · doi:10.1038/nature11010 · Cited by 554 · see citing works
Burnstock, G., Campbell, G. R., Satchell, D. G., et al. (1997) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1997.tb06815.x · Cited by 546 · see citing works
Yiangou, Y., Facer, P., Durrenberger, P., Chessell, I. P., Naylor, A., Bountra, C., Banati, R. R., & Anand, P. (2006) · BMC Neurology · doi:10.1186/1471-2377-6-12 · Cited by 509 · see citing works
The liberation of adenosine triphosphate on antidromic stimulation of sensory nerves
Holton, P. (1959) · The Journal of Physiology · doi:10.1113/jphysiol.1959.sp006157 · Cited by 501 · see citing works
Molloy, A., Laochumroonvorapong, P., & Kaplan, G. (1994) · The Journal of Experimental Medicine · doi:10.1084/jem.180.4.1499 · Cited by 501 · see citing works
Parvathenani, L. K., Tertyshnikova, S., Greco, C. R., Roberts, S. B., Robertson, B., & Posmantur, R. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209478200 · Cited by 488 · see citing works
The Permeabilizing ATP Receptor, P2X7
Rassendren, F., Buell, G. N., Virginio, C., Collo, G., North, R. A., & Surprenant, A. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.9.5482 · Cited by 479 · see citing works
Activation of neuronal P2X7 receptor–pannexin-1 mediates death of enteric neurons during colitis
Gulbransen, B. D., Bashashati, M., Hirota, S. A., Gui, X. S., Roberts, J. A., MacDonald, J. A., Muruve, D. A., McKay, D. M., Beck, P. L., Mawe, G. M., et al. (2012) · Nature Medicine · doi:10.1038/nm.2679 · Cited by 444 · see citing works
Graft-versus-host disease is enhanced by extracellular ATP activating P2X7R
Wilhelm, K., Ganesan, J., Müller, T., Dürr, C., Grimm, M., Beilhack, A., Krempl, C. D., Sorichter, S., Gerlach, U. V., Jüttner, E., et al. (2010) · Nature Medicine · doi:10.1038/nm.2242 · Cited by 435 · see citing works
Purinergic Signaling in the Cardiovascular System
Burnstock, G. (2017) · Circulation Research · doi:10.1161/circresaha.116.309726 · Cited by 420 · see citing works
Honoré, P., Donnelly‐Roberts, D. L., Namovic, M. T., Hsieh, G. C., Zhu, C., Mikusa, J. P., Hernandez, G., Zhong, C., Gauvin, D. M., Chandran, P., et al. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.111559 · Cited by 418 · see citing works
Matute, C., Torre, I., Pérez‐Cerdá, F., Pérez‐Samartín, A., Alberdi, E. M., Etxebarria, E., Arranz, A. M., Ravid, R., Antigüedad, A. R., Sánchez‐Gómez, M. V., et al. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.0579-07.2007 · Cited by 404 · see citing works
Brilliant Blue G Selectively Blocks ATP-Gated Rat P2X7Receptors
Jiang, L., Mackenzie, A. B., North, R. A., & Surprenant, A. (2000) · Molecular Pharmacology · doi:10.1124/mol.58.1.82 · Cited by 401 · see citing works
Purinergic Signalling: Therapeutic Developments
Burnstock, G. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00661 · Cited by 401 · see citing works
Extracellular ATP Is a Danger Signal Activating P2X7 Receptor in Lung Inflammation and Fibrosis
Riteau, N., Gasse, P., Fauconnier, L., Gombault, A., Couegnat, M., Fick, L., Kanellopoulos, J., Quesniaux, V. F. J., Marchand-Adam, S., Crestani, B., et al. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201003-0359oc · Cited by 397 · see citing works
P2X7 receptor: an emerging target in central nervous system diseases
Sperlágh, B., & Illes, P. (2014) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2014.08.002 · Cited by 390 · see citing works
Tumor Cell Death and ATP Release Prime Dendritic Cells and Efficient Anticancer Immunity
Aymeric, L., Apétoh, L., Ghiringhelli, F., Tesnière, A., Martins, I., Kroemer, G., Smyth, M. J., & Zitvogel, L. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3566 · Cited by 380 · see citing works
NLRs at the intersection of cell death and immunity
Ting, J. P.-Y., Willingham, S. B., & Bergstralh, D. T. (2008) · Nature Reviews Immunology · doi:10.1038/nri2296 · Cited by 371 · cited 1× · see citing works
“The later, in turn, processes pro-IL-1β to its mature form which is able to be released then (Ferrari et al., 1997, 2006; Qu et al., 2007; Ting et al., 2008; Di Virgilio et al., 2017).”
BackgroundExpression of P2X7 Receptor Increases In Vivo Tumor Growth
Adinolfi, E., Raffaghello, L., Giuliani, A. L., Cavazzini, L., Capece, M., Chiozzi, P., Bianchi, G., Kroemer, G., Pistoia, V., & Virgilio, F. D. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-1947 · Cited by 348 · see citing works
Virginio, C., MacKenzie, A., North, R. A., & Surprenant, A. (1999) · The Journal of Physiology · doi:10.1111/j.1469-7793.1999.0335m.x · Cited by 345 · see citing works
The P2X 7 purinergic receptor: from physiology to neurological disorders
Skaper, S. D., Debetto, P., & Giusti, P. (2009) · The FASEB Journal · doi:10.1096/fj.09-138883 · Cited by 336 · see citing works
Pharmacological characterization of recombinant human and rat P2X receptor subtypes
Bianchi, B. R., Lynch, K. J., Touma, E., Niforatos, W., Burgard, E. C., Alexander, K. M., Park, H. S., Yu, H., Metzger, R. E., Kowaluk, E. A., et al. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00350-7 · Cited by 331 · see citing works
Apolipoprotein E4 effects in Alzheimer’s disease are mediated by synaptotoxic oligomeric amyloid-β
Koffie, R. M., Hashimoto, T., Tai, H.-C., Kay, K. R., Serrano-Pozo, A., Joyner, D., Hou, S., Kopeikina, K. J., Frosch, M. P., Lee, V. M., et al. (2012) · Brain · doi:10.1093/brain/aws127 · Cited by 327 · see citing works
Keystone, E. C., Wang, M. M., Layton, M., Hollis, S., & McInnes, I. B. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2011-143578 · Cited by 318 · see citing works
Purines, Purinergic Receptors, and Cancer
Virgilio, F. D. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-1600 · Cited by 303 · see citing works
Activation of Microglia by Amyloid β Requires P2X7 Receptor Expression
Sanz, J. M., Chiozzi, P., Ferrari, D., Colaianna, M., Idzko, M., Falzoni, S., Fellin, R., Trabace, L., & Di Virgilio, F. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803612 · Cited by 293 · see citing works
Extracellular ATP mediates mast cell-dependent intestinal inflammation through P2X7 purinoceptors
Kurashima, Y., Amiya, T., Nochi, T., Fujisawa, K., Haraguchi, T., Iba, H., Tsutsui, H., Sato, S., Nakajima, S., Iijima, H., et al. (2012) · Nature Communications · doi:10.1038/ncomms2023 · Cited by 286 · see citing works
Schenk, U., Frascoli, M., Proietti, M., Geffers, R., Traggiai, E., Buer, J., Ricordi, C., Westendorf, A. M., & Grassi, F. (2011) · Science Signaling · doi:10.1126/scisignal.2001270 · Cited by 286 · see citing works
Autocrine regulation of T‐cell activation by ATP release and P2X 7 receptors
Yip, L., Woehrle, T., Corriden, R., Hirsh, M., Chen, Y., Inoue, Y., Ferrari, V., Insel, P. A., & JUNGER, W. G. (2009) · The FASEB Journal · doi:10.1096/fj.08-126458 · Cited by 284 · see citing works
McLarnon, J. G., Ryu, J. K., Walker, D. G., & Choi, H. B. (2006) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/01.jnen.0000240470.97295.d3 · Cited by 281 · see citing works
Evolutionary origins of the purinergic signalling system
Burnstock, G., & Verkhratsky, A. (2009) · Acta Physiologica · doi:10.1111/j.1748-1716.2009.01957.x · Cited by 277 · see citing works
Extracellular ATP drives systemic inflammation, tissue damage and mortality
Cauwels, A., Rogge, E., Vandendriessche, B., Shiva, S., & Brouckaert, P. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.70 · Cited by 275 · see citing works
Adinolfi, E., Callegari, M. G., Ferrari, D., Bolognesi, C., Minelli, M., Wieckowski, M. R., Pinton, P., Rizzuto, R., & Virgilio, F. D. (2005) · Molecular Biology of the Cell · doi:10.1091/mbc.e04-11-1025 · Cited by 272 · see citing works
Mammalian P2X7 receptor pharmacology: comparison of recombinant mouse, rat and human P2X7 receptors
Donnelly‐Roberts, D. L., Namovic, M. T., Han, P., & Jarvis, M. F. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00233.x · Cited by 271 · see citing works
North, R. A., & Jarvis, M. F. (2012) · Molecular Pharmacology · doi:10.1124/mol.112.083758 · Cited by 271 · see citing works
Sperlágh, B., Köfalvi, A., Deuchars, J., Atkinson, L., J. Milligan, C., Buckley, N. J., & Vizi, E. S. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00920.x · Cited by 264 · see citing works
Stock, T. C., Bloom, B. J., Wei, N., Ishaq, S., Park, W., WANG, X., Gupta, P. K., & MEBUS, C. A. (2012) · The Journal of Rheumatology · doi:10.3899/jrheum.110874 · Cited by 246 · see citing works
Arulkumaran, N., Unwin, R. J., & Tam, F. W. K. (2011) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2011.578068 · Cited by 241 · see citing works
Nelson, D. W., Gregg, R. J., Kort, M. E., Perez‐Medrano, A., Voight, E. A., Wang, Y., Grayson, G. K., Namovic, M. T., Donnelly‐Roberts, D. L., Niforatos, W., et al. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm051202e · Cited by 235 · see citing works
Holton, F. A., & Holton, P. (1954) · The Journal of Physiology · doi:10.1113/jphysiol.1954.sp005198 · Cited by 234 · see citing works
Fairbairn, I. P., Stober, C. B., Kumararatne, D. S., & Lammas, D. A. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.6.3300 · Cited by 234 · see citing works
Jacob, F., Perez-Novo, C. A., Bachert, C., & Crombruggen, K. V. (2013) · Purinergic Signalling · doi:10.1007/s11302-013-9357-4 · Cited by 232 · see citing works
The ATP4- receptor of rat mast cells
Cockcroft, S., & Gomperts, B. D. (1980) · Biochemical Journal · doi:10.1042/bj1880789 · Cited by 225 · see citing works
Dı́az-Hernández, M., Diez-Zaera, M., Sánchez‐Nogueiro, J., Gómez‐Villafuertes, R., Canals, J. M., Alberch, J., Miras‐Portugal, M. T., & Lucas, J. J. (2009) · The FASEB Journal · doi:10.1096/fj.08-122275 · Cited by 224 · see citing works
Molecular and functional properties of P2X receptors—recent progress and persisting challenges
Kaczmarek-Hájek, K., Lörinczi, É., Hausmann, R., & Nicke, A. (2012) · Purinergic Signalling · doi:10.1007/s11302-012-9314-7 · Cited by 223 · see citing works
P2Z/P2X7receptor-dependent apoptosis of dendritic cells
Coutinho‐Silva, R., Persechini, P. M., Bisaggio, R. D. C., Perfettini, J., Neto, A. C. T. D. S., Kanellopoulos, J., Motta, I., Dautry‐Varsat, A., & Ojcius, D. M. (1999) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1999.276.5.c1139 · Cited by 221 · see citing works
Self-citationActivation of NLRP3 and AIM2 Inflammasomes by Porphyromonas gingivalis Infection
Park, E.-J., Na, H. S., Song, Y., Shin, S. Y., Kim, Y., & Chung, J. (2013) · Infection and Immunity · doi:10.1128/iai.00862-13 · Cited by 219 · see citing works
Kahlenberg, J. M., Lundberg, K. C., Kertesy, S. B., Qu, Y., & Dubyak, G. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.11.7611 · Cited by 211 · see citing works
Jelassi, B., Chantôme, A., Alcaraz‐Pérez, F., Baroja‐Mazo, A., Cayuela, M. L., Pelegrı́n, P., Surprenant, A., & Roger, S. (2011) · Oncogene · doi:10.1038/onc.2010.593 · Cited by 209 · see citing works
Identification and characterization of splice variants of the human P2X7 ATP channel
Cheewatrakoolpong, B., Gilchrest, H., Anthes, J. C., & Greenfeder, S. A. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.04.087 · Cited by 207 · see citing works
P2X7 receptor expression in evolutive and indolent forms of chronic B lymphocytic leukemia
Adinolfi, E., Melchiorri, L., Falzoni, S., Chiozzi, P., Morelli, A., Tieghi, A., Cuneo, A., Castoldi, G., Virgilio, F. D., & Baricordi, O. R. (2002) · Blood · doi:10.1182/blood.v99.2.706 · Cited by 204 · see citing works
A role for tau at the synapse in Alzheimer’s disease pathogenesis
Pooler, A. M., Noble, W., & Hanger, D. P. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.09.018 · Cited by 203 · see citing works
A Polymorphism in the P2X7 Gene Increases Susceptibility to Extrapulmonary Tuberculosis
Fernando, S. L., Saunders, B. M., Sluyter, R., Skarratt, K. K., Goldberg, H., Marks, G. B., Wiley, J. S., & Britton, W. J. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200607-970oc · Cited by 203 · see citing works
In vivo P2X7 inhibition reduces amyloid plaques in Alzheimer's disease through GSK3β and secretases
Díaz‐Hernandéz, J. I., Gómez‐Villafuertes, R., León‐Otegui, M., Hontecillas‐Prieto, L., del Puerto, A., Trejo, J. L., Lucas, J. J., Garrido, J. J., Gualix, J., Miras‐Portugal, M. T., et al. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.09.040 · Cited by 201 · see citing works
CD39 limits P2X7 receptor inflammatory signaling and attenuates sepsis-induced liver injury
Savio, L. E. B., Mello, P. D. A., Figliuolo, V. R., Almeida, T. F. D. A., Santana, P. T., Oliveira, S. D., Silva, C. L. M., Feldbrügge, L., Csizmadia, E., Minshall, R. D., et al. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.05.021 · Cited by 197 · see citing works
Self-citationExtracellular ATP4- promotes cation fluxes in the J774 mouse macrophage cell line.
Steinberg, T. H., & Silverstein, S. C. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)61477-2 · Cited by 196 · see citing works
The cytokine IL‐1β transiently enhances P2X 7 receptor expression and function in human astrocytes
Narcisse, L., Scemes, E., Zhao, Y., Lee, S. C., & Brosnan, C. F. (2004) · Glia · doi:10.1002/glia.20110 · Cited by 191 · see citing works
Humphreys, B. D., & Dubyak, G. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.12.5627 · Cited by 189 · see citing works
Amoroso, F., Capece, M., Rotondò, A., Cangelosi, D., Ferracin, M., Franceschini, A., Raffaghello, L., Pistoia, V., Varesio, L., & Adinolfi, E. (2015) · Oncogene · doi:10.1038/onc.2014.444 · Cited by 187 · see citing works
Shimokawa, C., Kanaya, T., Hachisuka, M., Ishiwata, K., Hisaeda, H., Kurashima, Y., Kiyono, H., Yoshimoto, T., Kaisho, T., & Ohno, H. (2017) · Immunity · doi:10.1016/j.immuni.2017.04.017 · Cited by 187 · see citing works
Tsunoda, I., & Fujinami, R. S. (1996) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199606000-00001 · Cited by 184 · see citing works
Verkhratsky, A., & Burnstock, G. (2014) · BioEssays · doi:10.1002/bies.201400024 · Cited by 182 · see citing works
Proietti, M., Cornacchione, V., Rezzonico Jost, T., Romagnani, A., Faliti, C. E., Perruzza, L., Rigoni, R., Radaelli, E., Caprioli, F., Preziuso, S., et al. (2014) · Immunity · doi:10.1016/j.immuni.2014.10.010 · Cited by 181 · see citing works
Shieh, C., Heinrich, A., Serchov, T., van Calker, D., & Biber, K. (2014) · Glia · doi:10.1002/glia.22628 · Cited by 179 · see citing works
Accelerated Tumor Progression in Mice Lacking the ATP Receptor P2X7
Adinolfi, E., Capece, M., Franceschini, A., Falzoni, S., Giuliani, A. L., Rotondo, A., Sarti, A. C., Bonora, M., Syberg, S., Corigliano, D. M., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-1259 · Cited by 177 · see citing works
Astrocyte characterization in the multiple sclerosis glial scar
Holley, J., Gveric, D., Newcombe, J., Cuzner, M., & Gutowski, N. (2002) · Neuropathology and Applied Neurobiology · doi:10.1046/j.1365-2990.2003.00491.x · Cited by 176 · see citing works
Tafani, M., Schito, L., Pellegrini, L., Villanova, L., Marfè, G., Anwar, T., Rosa, R., Indelicato, M., Fini, M., Pucci, B., et al. (2011) · Carcinogenesis · doi:10.1093/carcin/bgr101 · Cited by 172 · see citing works
Hung, S.-C., Choi, C. H., Sadier, N. S., Johnson, L., Atanasova, K. R., Sellami, H., Yilmaz, Ö., & Ojcius, D. M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0070210 · Cited by 171 · see citing works
Yilmaz, Ö., Yao, L., Maeda, K., Rose, T. M., Lewis, E. L., Duman, M., Lamont, R. J., & Ojcius, D. M. (2008) · Cellular Microbiology · doi:10.1111/j.1462-5822.2007.01089.x · Cited by 165 · see citing works
Rapid ATP-induced release of matrix metalloproteinase 9 is mediated by the P2X7 receptor
Gu, B. J., & Wiley, J. S. (2006) · Blood · doi:10.1182/blood-2005-07-2994 · Cited by 160 · see citing works
Inhibition of Chlamydial Infectious Activity due to P2X7R-Dependent Phospholipase D Activation
Coutinho‐Silva, R., Welter-Stahl, L., Raymond, M., Jungas, T., Verbeke, P., Burnstock, G., Darville, T. L., & Ojcius, D. M. (2003) · Immunity · doi:10.1016/s1074-7613(03)00235-8 · Cited by 157 · see citing works
Self-citationKusner, D. J., & Adams, J. A. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.1.379 · Cited by 157 · see citing works
He, X., Mekasha, S., Mavrogiorgos, N. C., Fitzgerald, K. A., Lien, E., & Ingalls, R. R. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903937 · Cited by 157 · see citing works
Purinergic Signaling in the Airways
Burnstock, G., Brouns, I., Adriaensen, D., & Timmermans, J. (2012) · Pharmacological Reviews · doi:10.1124/pr.111.005389 · Cited by 157 · see citing works
Feng, Y., Li, X., Wang, L., Zhou, L., & Gorodeski, G. I. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602999200 · Cited by 152 · see citing works
Raffaghello, L., Chiozzi, P., Falzoni, S., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3185 · Cited by 152 · see citing works
Dagvadorj, J., Shimada, K., Chen, S., Jones, H. D., Tumurkhuu, G., Zhang, W., Wawrowsky, K., Crother, T. R., & Arditi, M. (2015) · Immunity · doi:10.1016/j.immuni.2015.03.007 · Cited by 146 · see citing works
Cohen, H. B., Briggs, K. T., Marino, J. P., Ravid, K., Robson, S. C., & Mosser, D. M. (2013) · Blood · doi:10.1182/blood-2013-04-496216 · Cited by 146 · see citing works
The P2X7 receptor is a key modulator of aerobic glycolysis
Amoroso, F., Falzoni, S., Adinolfi, E., Ferrari, D., & Virgilio, F. D. (2012) · Cell Death and Disease · doi:10.1038/cddis.2012.105 · Cited by 145 · see citing works
Pyruvate Carboxylase Affinity Labelling of the Magnesium Adenosine Triphosphate Binding Site
Easterbrook‐Smith, S. B., Wallace, J. C., & KEECH, D. B. (1976) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1976.tb10105.x · Cited by 144 · see citing works
A role for P2X 7 in microglial proliferation
Bianco, F., Ceruti, S., Colombo, A. V., Fumagalli, M., Ferrari, D., Pizzirani, C., Matteoli, M., Virgilio, F. D., Abbracchio, M. P., & Verderio, C. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04101.x · Cited by 143 · see citing works
Antagonists of the P2X7Receptor. From Lead Identification to Drug Development
Guile, S. D., Alcaraz, L., Birkinshaw, T. N., Bowers, K. C., Ebden, M. R., Furber, M., & Stocks, M. J. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm801528x · Cited by 142 · see citing works
Feng, L., Sun, X., Csizmadia, E., Han, L., Shu, B., Murakami, T., Wang, X., Robson, S. C., & Wu, Y. (2011) · Neoplasia · doi:10.1593/neo.101332 · Cited by 139 · see citing works
Csóka, B., Németh, Z. H., Törő, G., Idzko, M., Zech, A., Koscsó, B., Spolarics, Z., Antonioli, L., Cseri, K., Erdélyi, K., et al. (2015) · The FASEB Journal · doi:10.1096/fj.15-272450 · Cited by 139 · see citing works
Burnstock, G., Satchell, D. G., & Smythe, A. (1972) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1972.tb06868.x · Cited by 139 · see citing works
Eser, A., Colombel, J., Rutgeerts, P. J., Vermeire, S., Vogelsang, H., Braddock, M., Persson, T., & Reinisch, W. (2015) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000514 · Cited by 138 · see citing works
Hoque, R., Sohail, M. A., Salhanick, S. D., Malik, A. F., Ghani, A., Robson, S. C., & Mehal, W. Z. (2012) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00352.2011 · Cited by 138 · see citing works
Anthraquinone emodin inhibits human cancer cell invasiveness by antagonizing P2X7 receptors
Jelassi, B., Anchelin, M., Chamouton, J., Cayuela, M. L., Clarysse, L., Li, J., Goré, J., Jiang, L., & Roger, S. (2013) · Carcinogenesis · doi:10.1093/carcin/bgt099 · Cited by 136 · see citing works
Block of purinergic P2X7 receptor is neuroprotective in an animal model of Alzheimer's disease
Ryu, J. K., & McLarnon, J. G. (2008) · NeuroReport · doi:10.1097/wnr.0b013e3283179333 · Cited by 134 · see citing works
Cellular localization of P2X7 receptor mRNA in the rat brain
Yu, Y., Ugawa, S., Ueda, T., Ishida, Y., Inoue, K., Kyaw Nyunt, A., Umemura, A., Mase, M., Yamada, K., & Shimada, S. (2008) · Brain Research · doi:10.1016/j.brainres.2007.11.064 · Cited by 132 · see citing works
Lees, M. P., Fuller, S. J., McLeod, R. L., Boulter, N. R., Miller, C., Zakrzewski, A. M., Mui, E. J., Witola, W. H., Coyne, J. J., Hargrave, A. C., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000012 · Cited by 132 · see citing works
Rampe, D., Wang, L., & Ringheim, G. E. (2003) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2003.10.014 · Cited by 130 · see citing works
do Carmo, M. R. S., Menezes, A. P. F., Nunes, A. C. L., Pliássova, A., Rolo, A. P., Palmeira, C. M., Cunha, R. A., Canas, P. M., & de Andrade, G. M. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.01.045 · Cited by 129 · see citing works
ATP/P2X7 axis modulates myeloid-derived suppressor cell functions in neuroblastoma microenvironment
Bianchi, G., Vuerich, M., Pellegatti, P., Marimpietri, D., Emionite, L., Marigo, I., Bronte, V., Virgilio, F. D., Pistoia, V., & Raffaghello, L. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.109 · Cited by 128 · see citing works
Giannuzzo, A., Pedersen, S. F., & Novak, I. (2015) · Molecular Cancer · doi:10.1186/s12943-015-0472-4 · Cited by 128 · see citing works
P2X7 Mediates ATP-Driven Invasiveness in Prostate Cancer Cells
Qiu, Y., Li, W., Zhang, H., Liu, Y., Tian, X., & Fang, W. (2014) · PLoS ONE · doi:10.1371/journal.pone.0114371 · Cited by 126 · see citing works
Gonçalves, R. G., Gabrich, L., Rosário, A., Takiya, C. M., Ferreira, M. L. L., Chiarini, L. B., Persechini, P. M., Coutinho‐Silva, R., & Leite, M. (2006) · Kidney International · doi:10.1038/sj.ki.5001804 · Cited by 126 · see citing works
Self-citationGudipaty, L., Munetz, J., Verhoef, P. A., & Dubyak, G. (2003) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00070.2003 · Cited by 126 · see citing works
P2X7 Integrates PI3K/AKT and AMPK-PRAS40-mTOR Signaling Pathways to Mediate Tumor Cell Death
Shu, B., Sun, X., Bai, A., Zhang, C., Li, L., Enjyoji, K., JUNGER, W. G., Robson, S. C., & Wu, Y. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060184 · Cited by 125 · see citing works
P2Y2 Nucleotide Receptors Enhance α-Secretase-dependent Amyloid Precursor Protein Processing
Camden, J. M., Schrader, A. M., Camden, R. E., González, F. A., Erb, L., Seye, C. I., & Weisman, G. A. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500219200 · Cited by 125 · see citing works
Wang, H., Hong, L., Huang, J., Jiang, Q., Tao, R., Tan, C., Lu, N., Wang, C., Ahmed, M. M., Lu, Y., et al. (2015) · Cell Research · doi:10.1038/cr.2015.61 · Cited by 124 · see citing works
P2X7 receptor is critical in α-synuclein–mediated microglial NADPH oxidase activation
Jiang, T., Hoekstra, J., Heng, X., Kang, W., Ding, J., Liu, J., Chen, S., & Zhang, J. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.03.015 · Cited by 123 · see citing works
Purinergic signalling and diabetes
Burnstock, G., & Novak, I. (2013) · Purinergic Signalling · doi:10.1007/s11302-013-9359-2 · Cited by 121 · see citing works
P2X7 receptors stimulate AKT phosphorylation in astrocytes
Jacques-Silva, M. C., Rodnight, R., Lenz, G., Liao, Z., Kong, Q., Tran, M., Kang, Y., Gonzalez, F. A., Weisman, G. A., & Neary, J. T. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705685 · Cited by 121 · see citing works
P2X7 receptor-mediated apoptosis of human cervical epithelial cells
Wang, Q., Wang, L., Feng, Y., Li, X., Zeng, R., & Gorodeski, G. I. (2004) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00256.2004 · Cited by 120 · see citing works
Oxidized ATP (oATP) attenuates proinflammatory signaling via P2 receptor‐independent mechanisms
Beigi, R. D., Kertesy, S. B., Aquilina, G. R., & Dubyak, G. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705470 · Cited by 120 · see citing works
Sikora, A. G., Liu, J., Brosnan, C. F., Buell, G. N., Chessel, I., & Bloom, B. R. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.2.558 · Cited by 120 · see citing works
P2Z purinoceptor-associated pores induced by extracellular ATP in macrophages and J774 cells
Coutinho‐Silva, R., & Persechini, P. M. (1997) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1997.273.6.c1793 · Cited by 119 · see citing works
Self-citationShimada, K., Crother, T. R., Karlin, J. N., Chen, S., Chiba, N., Ramanujan, V. K., Vergnes, L., Ojcius, D. M., & Arditi, M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021477 · Cited by 118 · see citing works
Honoré, P., Donnelly‐Roberts, D. L., Namovic, M. T., Zhong, C., Wade, C. L., Chandran, P., Zhu, C., Carroll, W. A., Perez‐Medrano, A., Iwakura, Y., et al. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2009.05.018 · Cited by 116 · see citing works
Research Article Improving the PCR protocol to amplify a repetitive DNA sequence.
Riet, J., Ramos, L. R. V., Lewis, R. V., et al. (2017) · Genetics and Molecular Research · doi:10.4238/gmr16039796 · Cited by 116 · see citing works
Masin, M., Young, C., Lim, K., Barnes, S. J., Xu, X., Marschall, V., Brutkowski, W., Mooney, E. R., Górecki, D. C., & Murrell‐Lagnado, R. D. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01624.x · Cited by 112 · see citing works
Ali, Z., Laurijssens, B. E., Ostenfeld, T., McHugh, S. M., Stylianou, A., Scott‐Stevens, P., Hosking, L. K., Dewit, O., Richardson, J. C., & Chen, C. (2012) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2012.04320.x · Cited by 111 · see citing works
P2X7 Receptor as a Therapeutic Target
Marchi, E. D., Orioli, E., Ben, D. D., & Adinolfi, E. (2016) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2015.11.004 · Cited by 111 · see citing works
P2X7 receptor and NLRP3 inflammasome activation in head and neck cancer
Bae, J. Y., Lee, S.-W., Shin, Y., Lee, J.-H., Jahng, J. W., & Park, K. (2017) · Oncotarget · doi:10.18632/oncotarget.16903 · Cited by 111 · see citing works
Mouse pancreatic islet macrophages use locally released ATP to monitor beta cell activity
Weitz, J., Makhmutova, M., Almaça, J., Stertmann, J., Aamodt, K. I., Briššová, M., Speier, S., Rodriguez‐Diaz, R., & Caicedo, A. (2017) · Diabetologia · doi:10.1007/s00125-017-4416-y · Cited by 111 · see citing works
Hofman, P. M., Cherfils‐Vicini, J., Bazin, M., Ilié, M., Juhel, T., Hébuterne, X., Gilson, É., Schmid‐Alliana, A., Boyer, O., Adriouch, S., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-1778 · Cited by 110 · see citing works
Delarasse, C., Auger, R., Gonnord, P., Fontaine, B., & Kanellopoulos, J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.200618 · Cited by 108 · see citing works
Boucher, A. A., Arnold, J. C., Hunt, G. E., Spiro, A., Spencer, J., Brown, C., McGregor, I. S., Bennett, M. R., & Kassiou, M. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.05.049 · Cited by 108 · see citing works
Long-Term Heart Transplant Survival by Targeting the Ionotropic Purinergic Receptor P2X7
Vergani, A., Tezza, S., D’Addio, F., Fotino, C., Liu, K., Niewczas, M. A., Bassi, R., Molano, R. D., Kleffel, S., Petrelli, A., et al. (2012) · Circulation · doi:10.1161/circulationaha.112.123653 · Cited by 108 · see citing works
Neves, A. R., Castelo-Branco, M. T. L., Figliuolo, V. R., Bernardazzi, C., Buongusto, F., Yoshimoto, A., Nanini, H. F., Coutinho, C. M. L. M., Carneiro, A. J. V., Coutinho-Silva, R., et al. (2014) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000441201.10454.06 · Cited by 107 · see citing works
Self-citationSolini, A., Menini, S., Rossi, C., Ricci, P. C., Santini, E., Fantauzzi, C. B., Iacobini, C., & Pugliese, G. (2013) · The Journal of Pathology · doi:10.1002/path.4237 · Cited by 107 · see citing works
Adinolfi, E., Callegari, M. G., Cirillo, M., Pinton, P., Giorgi, C., Cavagna, D., Rizzuto, R., & Virgilio, F. D. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m805805200 · Cited by 107 · see citing works
Hill, L. M., Gavala, M. L., Lenertz, L. Y., & Bertics, P. J. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1001298 · Cited by 107 · see citing works
Modulation of P2Z/P2X7receptor activity in macrophages infected withChlamydia psittaci
Coutinho‐Silva, R., Perfettini, J., Persechini, P. M., Dautry‐Varsat, A., & Ojcius, D. M. (2001) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.2001.280.1.c81 · Cited by 107 · see citing works
Self-citationEvidence for associations between the purinergic receptor P2X7 (P2RX7) and toxoplasmosis
Jamieson, S., Rangel, A. L. P., Hargrave, A. C., de Roubaix, L.-A., Mui, E. J., Boulter, N. R., Miller, E. N., Fuller, S. J., Wiley, J. S., Castellucci, L. C., et al. (2010) · Genes and Immunity · doi:10.1038/gene.2010.31 · Cited by 105 · see citing works
Purinergic signaling in kidney disease
Menzies, R. I., Tam, F. W. K., Unwin, R. J., & Bailey, M. A. (2016) · Kidney International · doi:10.1016/j.kint.2016.08.029 · Cited by 105 · see citing works
Moreira-Souza, A. C. A., Almeida-da-Silva, C. L. C., Rangel, T. P., Rocha, G. D. C., Bellio, M., Zamboni, D. S., Vommaro, R. C., & Coutinho‐Silva, R. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01257 · Cited by 105 · see citing works
Self-citationJiang, S., Zhang, Y., Zheng, J., Li, X., Yao, Y., Wu, Y., Song, S., Sun, P., Nan, J., & Lian, L. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.11.040 · Cited by 104 · see citing works
Gilbert, S. M., Baird, A. G., Glazer, S., Barden, J. A., Glazer, A., Teh, L. C., & King, J. (2017) · British Journal of Dermatology · doi:10.1111/bjd.15364 · Cited by 104 · see citing works
Purinergic receptor P2X7: A novel target for anti-inflammatory therapy
Mehta, N., Kaur, M., Singh, M., Chand, S., Vyas, B., Silakari, P., Bahia, M. S., & Silakari, O. (2013) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2013.10.054 · Cited by 103 · see citing works
Choi, C. H., Spooner, R., DeGuzman, J., Koutouzis, T., Ojcius, D. M., & Yilmaz, Ö. (2012) · Cellular Microbiology · doi:10.1111/cmi.12089 · Cited by 102 · see citing works
Lee, B. H., Hwang, D. M., Palaniyar, N., Grinstein, S., Philpott, D. J., & Hu, J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035812 · Cited by 102 · see citing works
Ecto-5′-Nucleotidase (CD73) Decreases Mortality and Organ Injury in Sepsis
Haskó, G., Csóka, B., Koscsó, B., Chandra, R., Pacher, P., Thompson, L. F., Deitch, E. A., Spolarics, Z., Virág, L., Gergely, P., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003379 · Cited by 102 · see citing works
Roger, S., Jelassi, B., Couillin, I., Pelegrı́n, P., Besson, P., & Jiang, L. (2014) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2014.10.029 · Cited by 101 · see citing works
Targeting of the P2X7 receptor in pancreatic cancer and stellate cells
Giannuzzo, A., Saccomano, M., Napp, J., Ellegaard, M., Alves, F., & Novak, I. (2016) · International Journal of Cancer · doi:10.1002/ijc.30380 · Cited by 101 · see citing works
Mello, P. D. A., Coutinho‐Silva, R., & Savio, L. E. B. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01526 · Cited by 100 · see citing works
Self-citationTh2 and Th1 Responses: Clear and Hidden Sides of Immunity Against Intestinal Helminths
Cortés, A., Muñoz-Antolí, C., Esteban, J. G., & Toledo, R. (2017) · Trends in Parasitology · doi:10.1016/j.pt.2017.05.004 · Cited by 99 · see citing works
Corrêa, G., Marques-da-Silva, C., Moreira-Souza, A. C. A., Vommaro, R. C., & Coutinho‐Silva, R. (2010) · Microbes and Infection · doi:10.1016/j.micinf.2010.03.004 · Cited by 98 · see citing works
Self-citationAmaral, E. P., Ribeiro, S. C. M., Lanes, V. R., Almeida, F. M., de Andrade, M. R. M., Bomfim, C. C. B., de Salles, É. M., Bortoluci, K. R., Coutinho‐Silva, R., Hirata, M. H., et al. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004188 · Cited by 97 · see citing works
Self-citationNLRP3 Inflammasome Activation in Dialyzed Chronic Kidney Disease Patients
Granata, S., Masola, V., Zoratti, E., Scupoli, M. T., Baruzzi, A., Messa, M., Sallustio, F., Gesualdo, L., Lupo, A., & Zaza, G. (2015) · PLoS ONE · doi:10.1371/journal.pone.0122272 · Cited by 97 · see citing works
BRADFORD, M. D., & Soltoff, S. P. (2002) · Biochemical Journal · doi:10.1042/bj20020358 · Cited by 97 · see citing works
Marcellino, D., Suárez-Boomgaard, D., Sánchez-Reina, M. D., Aguirre, J. A., Yoshitake, T., Yoshitake, S., Hagman, B., Kehr, J., Agnati, L. F., Fuxe, K., et al. (2010) · Journal of Neural Transmission · doi:10.1007/s00702-010-0400-0 · Cited by 97 · see citing works
Trophic Activity of Human P2X7 Receptor Isoforms A and B in Osteosarcoma
Giuliani, A. L., Colognesi, D., Ricco, T., Roncato, C., Capece, M., Amoroso, F., Wang, Q., Marchi, E. D., Gartland, A., Virgilio, F. D., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0107224 · Cited by 97 · see citing works
Purinergic signaling during intestinal inflammation
Longhi, M. S., Moss, A. C., Jiang, Z. G., & Robson, S. C. (2017) · Journal of Molecular Medicine · doi:10.1007/s00109-017-1545-1 · Cited by 97 · see citing works
Baxter, M. D., Eltom, S. M., Dekkak, B., Yew‐Booth, L., Dubuis, E. D., Maher, S. A., Belvisi, M. G., & Birrell, M. A. (2014) · Thorax · doi:10.1136/thoraxjnl-2014-205467 · Cited by 95 · see citing works
Kim, S. Y., Moon, J. H., Lee, H. G., Kim, S. U., & Lee, Y. B. (2007) · Experimental & Molecular Medicine · doi:10.1038/emm.2007.89 · Cited by 93 · see citing works
ATP Signaling in Brain: Release, Excitotoxicity and Potential Therapeutic Targets
Cisneros-Mejorado, A., Pérez‐Samartín, A., Gottlieb, M., & Matute, C. (2014) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-014-0092-3 · Cited by 93 · see citing works
Purinergic signalling in the kidney in health and disease
Burnstock, G., Evans, L. C., & Bailey, M. A. (2013) · Purinergic Signalling · doi:10.1007/s11302-013-9400-5 · Cited by 92 · see citing works
Alves, L. A., Soares‐Bezerra, R. J., Faria, R. X., Ferreira, L., & Frutuoso, V. D. S. (2013) · Molecules · doi:10.3390/molecules180910953 · Cited by 92 · see citing works
Purinergic Receptors Are Required for HIV-1 Infection of Primary Human Macrophages
Hazleton, J. E., Berman, J. W., & Eugenín, E. A. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1102482 · Cited by 92 · see citing works
P2X7 receptor antagonists: a patent review (2010–2015)
Park, J.-H., & Kim, Y. (2016) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2017.1246538 · Cited by 92 · see citing works
Metzger, M. W., Walser, S. M., Aprile-Garcia, F., Dedic, N., Chen, A., Holsboer, F., ARZT, E. S., Wurst, W., & Deussing, J. M. (2016) · Purinergic Signalling · doi:10.1007/s11302-016-9546-z · Cited by 92 · see citing works
Jun, D., Kim, J. J., Jung, S., Song, R., Noh, J.-H., Park, Y., Ryu, S. H., Kim, J., Kong, Y., Chung, J.-M., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m707915200 · Cited by 91 · see citing works
Coutinho‐Silva, R., & Ojcius, D. M. (2012) · Microbes and Infection · doi:10.1016/j.micinf.2012.05.009 · Cited by 91 · see citing works
Self-citationExpression of P2X7 in human hematopoietic cell lines and leukemia patients
Zhang, X., Zheng, G., Ma, X., Yang, Y.-H., Li, G., Rao, Q., Nie, K., & Wu, K. (2004) · Leukemia Research · doi:10.1016/j.leukres.2004.04.001 · Cited by 90 · see citing works
Glas, R., Sauter, N. S., Schulthess, F. T., Shu, L., Oberholzer, J., & Maedler, K. (2009) · Diabetologia · doi:10.1007/s00125-009-1349-0 · Cited by 90 · see citing works
Placido, R., Auricchio, G., Falzoni, S., Battistini, L., Colizzi, V., Brunetti, E., Virgilio, F. D., & Mancino, G. (2006) · Cellular Immunology · doi:10.1016/j.cellimm.2007.02.001 · Cited by 89 · see citing works
Sater, A. A. A., Sadier, N. S., Padilla, E. V., & Ojcius, D. M. (2010) · Microbes and Infection · doi:10.1016/j.micinf.2010.04.008 · Cited by 88 · see citing works
Hyperglycemia-induced Renal P2X7 Receptor Activation Enhances Diabetes-related Injury
Menzies, R. I., Booth, J. W. R., Mullins, J. J., Bailey, M. A., Tam, F. W. K., Norman, J. T., & Unwin, R. J. (2017) · EBioMedicine · doi:10.1016/j.ebiom.2017.04.011 · Cited by 88 · see citing works
Chaves, S. P., Torres-Santos, E. C., Marques, C. F. D. O., Figliuolo, V. R., Persechini, P. M., Coutinho‐Silva, R., & Rossi‐Bergmann, B. (2009) · Microbes and Infection · doi:10.1016/j.micinf.2009.05.001 · Cited by 87 · see citing works
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
DAMP-sensing receptors in sterile inflammation and inflammatory diseases
Gong, T., Liu, L., Jiang, W., & Zhou, R. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-019-0215-7 · Cited by 1,672 · see citing works
P2X7 Interactions and Signaling – Making Head or Tail of It
Kopp, R., Krautloher, A., Ramírez-Fernández, A., & Nicke, A. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00183 · Cited by 217 · see citing works
The P2X7 Receptor: Central Hub of Brain Diseases
Andrejew, R., Oliveira-Giacomelli, Á., Ribeiro, D. E., Glaser, T., Arnaud-Sampaio, V. F., Lameu, C., & Ulrich, H. (2020) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.00124 · Cited by 162 · see citing works
Hyperactivation of P2X7 receptors as a culprit of COVID-19 neuropathology
Ribeiro, D. E., Oliveira-Giacomelli, Á., Glaser, T., Arnaud-Sampaio, V. F., Andrejew, R., Dieckmann, L., Baranova, J., Lameu, C., Ratajczak, M. Z., & Ulrich, H. (2021) · Molecular Psychiatry · doi:10.1038/s41380-020-00965-3 · Cited by 145 · see citing works
Role of P2X7 Receptors in Immune Responses During Neurodegeneration
Oliveira-Giacomelli, Á., Petiz, L. L., Andrejew, R., Turrini, N., Silva, J. B., Sack, U., & Ulrich, H. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.662935 · Cited by 68 · see citing works
The role of macrophages in protective and pathological responses to <i>Toxoplasma gondii</i>
Park, J., & Hunter, C. A. (2020) · Parasite Immunology · doi:10.1111/pim.12712 · Cited by 54 · see citing works
Pleiotropic Roles of P2X7 in the Central Nervous System
Kanellopoulos, J. M., & Delarasse, C. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00401 · Cited by 48 · see citing works
Crabbé, M., Van der Perren, A., Bollaerts, I., Kounelis, S., Baekelandt, V., Bormans, G., Casteels, C., Moons, L., & Van Laere, K. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00799 · Cited by 49 · see citing works
- Authors
- Savio, L. E. B., de Andrade Mello, P., da Silva, C. G., & Coutinho-Silva, R.
- Affiliations
- Universidade Federal do Rio de Janeiro (BR)
- ORCID
- Savio, Luiz E. B.
- Venue
- Frontiers in Pharmacology
- Publisher
- Frontiers Media SA
- Published
- 2018-02-06
- Volume
- 9
- Pages
- 52-52
- ISSN
- 1663-9812 (ISSN-L)
- PMC
- PMC5808178
- OpenAlex
- W2793479725
- Cited by
- 437
- References
- 377
- Citations by year
- 2026: 38 · 2025: 43 · 2024: 56 · 2023: 52 · 2022: 49 · 2021: 66 · 2020: 71 · 2019: 45 · 2018: 17
- FWCI
- 5.87
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Frontiers in Pharmacology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (05/2016, Edital 05/2016)
- Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro (Nota-10)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Physiology › Adenosine and Purinergic Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Health Sciences › Medicine › Nephrology › Gout, Hyperuricemia, Uric Acid
- Keywords
- P2X7 receptor, purinergic signaling, extracellular ATP, inflammatory diseases, inflammasome activation, IL-1β, IL-18, caspase activation, Th17/Treg balance, neuroinflammation, neurodegenerative diseases, infectious diseases, cancer, pharmacological modulation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review